ArticleCancers2020

Chemoembolization Plus Radiotherapy Versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis.

Hee Ho Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.